Author: Melnik, Lilia I; Garry, Robert F; Morris, Cindy A
Title: Peptide inhibition of human cytomegalovirus infection Document date: 2011_2_22
ID: 0p6x4lwx_5
Snippet: The lack of a successful HCMV vaccine as well as the toxicity and drug-induced resistance associated with current therapeutics for HCMV indicate that this virus continues to pose a significant public health problem. Current treatments for HCMV disease target viral replication and can fail due to the emergence of drug-resistant virus variants and induction of adverse effects. Hence, a new approach in drug design against HCMV is required [26, 27] ......
Document: The lack of a successful HCMV vaccine as well as the toxicity and drug-induced resistance associated with current therapeutics for HCMV indicate that this virus continues to pose a significant public health problem. Current treatments for HCMV disease target viral replication and can fail due to the emergence of drug-resistant virus variants and induction of adverse effects. Hence, a new approach in drug design against HCMV is required [26, 27] . Since HCMV and other herpesviruses establish a lifelong latency in humans, antiviral therapy that inhibits viral entry may serve as an alternative to the already existing and inadequate therapeutic agents. Here, we report the design, development and characterization of peptides that specifically inhibit viral infection and/or entry as a novel approach to prevent HCMV infection.
Search related documents:
Co phrase search for related documents- adverse effect and current treatment: 1, 2, 3
- adverse effect and new approach: 1
- adverse effect and novel approach: 1
- adverse effect and public health: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
- adverse effect and public health problem: 1, 2, 3, 4, 5
- adverse effect and significant public health problem: 1
- adverse effect and viral entry: 1, 2
- adverse effect and viral infection: 1, 2, 3, 4, 5
- adverse effect and viral replication: 1, 2, 3, 4
- antiviral therapy and current therapeutic: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- antiviral therapy and current treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- antiviral therapy and drug design: 1, 2, 3, 4, 5, 6
- antiviral therapy and drug induce: 1, 2
- antiviral therapy and drug induce resistance: 1, 2
- antiviral therapy and hcmv infection: 1
- antiviral therapy and hcmv vaccine: 1
- antiviral therapy and new approach: 1, 2, 3, 4, 5, 6, 7
- antiviral therapy and novel approach: 1, 2, 3, 4
- antiviral therapy and public health: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
Co phrase search for related documents, hyperlinks ordered by date